Paris, France

Cécile Dupont

This inventor holds 10 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Brightheart Sas, Safeheal Sas, Safeheal. Active years: 2023-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cécile Dupont. Retrieved from https://idiyas.com/inventor/cécile-dupont

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.4

ph-index = 4

Forward Citations = 40(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Cécile Dupont: Innovator in Fetal Cardiology

Introduction

Cécile Dupont is a prominent inventor based in Paris, France, known for his significant contributions to the field of fetal cardiology. With a total of eight patents to his name, Dupont has focused on developing advanced systems and methods for improving the detection of congenital heart defects in fetuses. His work combines cutting-edge technology with medical imaging to enhance diagnostic capabilities.

Latest Patents

One of Dupont's latest patents is titled "Systems and methods for improving detection of fetal congenital heart defects." This innovation provides a framework for aiding the detection and diagnosis of critical heart defects during fetal ultrasound examinations. The system utilizes machine learning algorithms to analyze image data, such as motion video clips and image frames, to identify morphological and flow abnormalities indicative of critical congenital heart defects (CHDs). The results are presented for clinician review, with options for graphical or textual annotations to create a documentary record of the examination.

Another notable patent is "Systems and methods for detecting cardiovascular anomalies using spatiotemporal neural networks." This invention processes image data generated by medical imaging devices, such as ultrasounds or echocardiograms, using artificial intelligence and machine learning. The system determines the presence of congenital heart defects and other cardiovascular anomalies by employing a spatiotemporal convolutional neural network (CNN). This innovative approach fuses outputs from spatial and temporal CNNs to enhance the likelihood of detecting CHDs and other anomalies.

Career Highlights

Throughout his career, Cécile Dupont has worked with several notable companies, including Brightheart SAS and Safeheal SAS. His experience in these organizations has allowed him to refine his expertise in medical imaging and artificial intelligence applications in healthcare.

Collaborations

Dupont has collaborated with talented professionals in his field, including Christophe Gardella and Charam Khosrovaninejad. These partnerships have contributed to the advancement of his innovative projects and the successful development of his patented technologies.

Conclusion

Cécile Dupont stands out as a leading inventor in the realm of fetal cardiology, with a focus on enhancing diagnostic methods for congenital heart defects. His innovative patents and collaborations reflect his commitment to improving healthcare outcomes for expectant families.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…